SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-110876
Filing Date
2018-04-09
Accepted
2018-04-09 06:08:56
Documents
5
Period of Report
2018-05-14
Effectiveness Date
2018-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d463492ddef14a.htm DEF 14A 904359
2 GRAPHIC g463492dsp0.jpg GRAPHIC 1000
3 GRAPHIC g463492g51l25.jpg GRAPHIC 34826
4 GRAPHIC g463492g89s35.jpg GRAPHIC 22346
5 GRAPHIC g463492g93y50.jpg GRAPHIC 1987
  Complete submission text file 0001193125-18-110876.txt   988910
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 18744472
SIC: 2834 Pharmaceutical Preparations